Contraceptive technologies: how much choice do we really have?
Fishel
J
J
D000028:Abortion, Induced; D000569:Americas; D001695:Biology; D003267:Contraception; D003269:Contraception, Immunologic; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003272:Contraceptive Agents, Male; D003274:Contraceptive Devices, Female; D003281:Contraceptives, Postcoital; D019049:Developed Countries; D004467:Economics; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005376:Financial Management; D006727:Hormone Antagonists; D006728:Hormones; D007267:Injections; D007434:Intrauterine Devices; D007878:Legislation as Topic; D015735:Mifepristone; D009656:North America; D010827:Physiology; D014481:United States; D022642:Vaccines, Contraceptive
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003272:Contraceptive Agents, Male; D003281:Contraceptives, Postcoital; D006727:Hormone Antagonists; D006728:Hormones; D022642:Vaccines, Contraceptive; D015735:Mifepristone
Abortion, Drug Induced; Abortion, Induced; Americas; Barrier Methods; Biology; Contraception; Contraception Research; Contraception, Immunological; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Contraceptive Agents, Postcoital; Contraceptive Implants; Contraceptive Methods; Contraceptive Vaccines; Critique; Developed Countries; Economic Factors; Endocrine System; Family Planning; Fertility Control, Postcoital; Fertility Control, Postconception; Financial Activities; Funds; Hormone Antagonists; Hormones; Injectables; Iud; Legislation; North America; Northern America; Physiology; Ru-486; United States; Vaginal Rings